Are you Dr. Schlegel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 S Sherman St
Spokane, WA 99202Phone+1 509-228-1000Fax+1 509-252-9300
Summary
- Dr. Peter Schlegel, MD is an oncologist in Spokane, Washington. He is currently licensed to practice medicine in Washington, Idaho, and Utah. He is affiliated with Providence Sacred Heart Medical Center & Children's Hospital, Mann-Grandstaff Department of Veterans Affairs Medical Center, and MultiCare Valley Hospital.
Education & Training
- University of Utah HealthFellowship, Hematology and Medical Oncology, 1997 - 1999
- University of Utah HealthResidency, Internal Medicine, 1994 - 1997
- Rush Medical College of Rush University Medical CenterClass of 1994
Certifications & Licensure
- WA State Medical License 1999 - 2026
- ID State Medical License 2008 - 2025
- UT State Medical License 1996 - 2000
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011
Publications & Presentations
PubMed
- 4 citationsA multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxe...Hani M. Babiker, Peter J. Schlegel, Lee G. Hicks, Andrea J. Bullock, Nafisa Burhani
Investigational New Drugs. 2021-08-21 - 67 citationsResults of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphomaNicholas J. Di Bella, Raymond Taetle, Kathryn S. Kolibaba, Thomas E. Boyd, Robert N. Raju
Blood. 2008-11-16 - 5 citationsAutoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia and renal cell carcinoma after treatment with high-dose intravenous bolus interleukin-2.Peter J Schlegel, Wolfram E. Samlowski, John H. Ward
Journal of Immunotherapy. 2000-07-01
Professional Memberships
- Member